MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
18.99
-0.11 (-0.58%)
Aug 4, 2026, 4:00 PM EDT - Market closed

MiniMed Group Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Revenue
3,1023,1022,7152,4692,245
Revenue Growth
14.25%14.25%9.96%9.98%-
Gross Profit
1,6801,6801,5281,4361,308
Operating Income
-190-190-146-69-69
Net Income
-333-333-213-112-96
Earnings Per Share
-1.30-1.30-0.84-0.44-
EPS Growth
-----

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Pumps
587546541540477
Consumables
929956854777760
Continuous Glucose Monitoring (CGM)
1,4851,5531,3131,117958
Other Segment
374663450
Revenue (Total)
3,1023,1022,7152,4692,245

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Net Cash (Debt)
298298115458
Net Cash Growth
2609.09%2609.09%-79.63%-6.90%-
Cash & Investments
298298115458
Net Cash Per Share
1.161.160.040.21-

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Operating Cash Flow
-197-19714041-6
Capital Expenditures
-223-223-193-148-167
Free Cash Flow
-420-420-53-107-173
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23
Gross Margin
54.16%54.16%56.28%58.16%58.26%
Operating Margin
-6.13%-6.13%-5.38%-2.79%-3.07%
Pretax Margin
-6.09%-6.09%-5.41%-2.84%-3.39%
Profit Margin
-10.22%-10.22%-7.29%-4.33%-4.10%
FCF Margin
-13.54%-13.54%-1.95%-4.33%-7.71%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingAug '26 Apr '26 Apr '25 Apr '24 Apr '23
Forward PE
30.1843.29---
PS Ratio
1.721.19---